Founded in 2010, Siesta Medical is dedicated to providing innovative health and allied services, with a core mission to improve the quality of life for individuals suffering from obstructive sleep apnea (OSA). The company's flagship product, AIRLIFT, offers a simple, effective, and lasting treatment for OSA through hyoid and tongue suspension procedures. Siesta Medical focuses on delivering solutions that enable patients to breathe better without relying on traditional masks, targeting a market of sleep apnea sufferers seeking more permanent and comfortable treatment options.
Siesta Medical has garnered attention from notable figures in the medical community and investors who recognize the potential of its AIRLIFT system. The company has achieved significant milestones, including securing patents and publishing research that underscores the efficacy of their treatment. Through its innovative approach, Siesta Medical has made a substantial impact on the lives of patients by providing an alternative to conventional sleep apnea therapies, thereby enhancing overall patient health and well-being.
